Answer
Yes, cases of diverticulitis and gastrointestinal perforation have been reported with baricitinib in clinical trials and from postmarketing sources.
Sources for this answer
- Baricitinib LillyEli Lilly and Company Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 6Document updated
Sources checked